Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Radiation × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2 Thoracic 1 Genitourinary 1 Dermatologic 1 CNS 1

Conditions

Melanoma 18 Skin Neoplasms 5 Carcinoma, Merkel Cell 5 Sarcoma 4 Breast Neoplasms 3 Mycosis Fungoides 2 Head and Neck Neoplasms 2 Glioblastoma 2 Esophageal Neoplasms 2 Brain Neoplasms 2 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Diseases 1 Sezary Syndrome 1 Sarcoma, Synovial 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Parotid Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasm Metastasis 1

Interventions

Peripheral Blood Stem Cell Transplantation 17 fludarabine phosphate 15 Cyclophosphamide 14 Mycophenolic Acid 13 Cyclosporine 13 Whole-Body Irradiation 12 Tacrolimus 8 Radiotherapy 8 Methotrexate 7 Melphalan 7 Busulfan 7 pembrolizumab 6 Antilymphocyte Serum 6 Nivolumab 5 Methylprednisolone 5 Filgrastim 5 Etoposide 5 Sirolimus 4 Therapeutics 3 Polymerase Chain Reaction 3 Cord Blood Stem Cell Transplantation 3 sargramostim 2 merphos 2 bempegaldesleukin 2 Vitamin B 12 2 Transplantation 2 Surgical Procedures, Operative 2 Prednisone 2 Oxaliplatin 2 Ondansetron 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00975520 2024-11-27

RTN2

Melanoma and Skin Cancer Trials Limited

Phase NA Completed

Melanoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡